Diagnostic News and Research

RSS

New genotype may be responsible for sharp rise in whooping cough

Australia's prolonged whooping cough epidemic has entered a disturbing new phase, with a study showing a new strain or genotype may be responsible for the sharp rise in the number of cases.

22 Mar 2012

Heart Failure Congress 2012 to take place from May 19-22

Four days of scientific sessions will be devoted to the latest advances and controversies in heart failure at this year's Heart Failure Congress 2012. The latest results from drugs and devices trials will be announced at the meeting.

21 Mar 2012

OSU, NCKU sign MOU to improve clinical research on pancreatic cancer

National Cheng Kung University (NCKU) in Tainan, southern Taiwan, signed a memorandum of understanding (MOU) with the Ohio State University (OSU) College of Pharmacy on March 20 at the NCKU College of Medicine as part of its effort to enhance its international academic cooperation and most importantly to improve the clinical research on pancreatic cancer.

21 Mar 2012

Sharp rise recorded in cases of new strain of whooping cough: New genotype may be evading vaccine’s protective effects

Australia’s prolonged whooping cough epidemic has entered a disturbing new phase, with a study showing a new strain or genotype may be responsible for the sharp rise in the number of cases.

20 Mar 2012

n3D releases new 24-well Bio-Assembler

Only days after Rainbow BioSciences closed a deal to acquire an equity interest in Nano3D Biosciences, n3D announced the release of its groundbreaking new 24-well Bio-Assembler.

20 Mar 2012

Researchers discover new method to identify cancer-causing translocations

Researchers from Huntsman Cancer Institute (HCI) at the University of Utah report they have discovered a method to identify cancer-causing rearrangements of genetic material called chromosomal translocations quickly, accurately, and inexpensively.

20 Mar 2012

MabCure, CUNY CAT partner to evaluate monoclonal antibodies against ovarian cancer cells

MabCure Inc., leading developer of antibody based technology for the diagnosis and treatment of Ovarian, Prostate, Colorectal and other cancers today announced it has entered into an agreement with the City University of New York Center for Advanced Technology (CUNY CAT) to evaluate its monoclonal antibodies against ovarian cancer cells as diagnostic reagents.

19 Mar 2012

New medical education portal - Lipoprotein Perspectives - launched

LipoScience, Inc., an in vitro diagnostic company advancing patient care by developing high value proprietary clinical tests using nuclear magnetic resonance (NMR) technology, announced the launch of Lipoprotein Perspectives - a medical education portal featuring experts in clinical and preventive cardiology, endocrinology, and lipidology - at www.lipoprotein.org.

19 Mar 2012

Ventana launches novel platform for special stains

Ventana Medical Systems, Inc., a member of the Roche Group, is now introducing a novel platform for special stains, built on its industry-leading VENTANA BenchMark technology.

19 Mar 2012

DBS introduces novel Multiplex Immunohistochemistry cancer kits

Diagnostic Biosystems, a specialty Immunohistochemistry company, announces its debut as an automated IHC company, introducing the Mosaic 360 System with a product offering of novel Multiplex Immunohistochemistry kits and a complementary line of optimized IHC reagents.

19 Mar 2012

Biomedical Systems launches wireless ambulatory ECG monitoring system for management of AF

Biomedical Systems, a global provider of cardiac diagnostic services and products, has introduced the TruVue® Wireless Ambulatory ECG Monitoring System for the diagnosis and management of atrial fibrillation and other complex cardiac arrhythmia.

19 Mar 2012

Study confirms value of Cambridge Heart's MTWA test for SCA

Cambridge Heart, Inc., a developer of non-invasive diagnostic tests for cardiac disease, today announced that a new study published on-line in the Heart Rhythm Journal confirms the value of Microvolt T-Wave Alternans (MTWA) testing for identifying patients at risk of sudden cardiac arrest.

19 Mar 2012

Japan's MHLW provides reimbursement coverage for MTWA test

Cambridge Heart, Inc., a developer of non-invasive diagnostic tests for cardiac disease, today announced that its Microvolt T-Wave Alternans (MTWA) test received reimbursement coverage from Japan's Ministry of Health, Labor and Welfare (MHLW).

17 Mar 2012

Sysmex America announces selection to Center for Companies That Care's 2012 Honor Roll

Sysmex America, Inc., a global leader in medical diagnostic testing equipment and information systems technology, today announces its selection to Center for Companies That Care's 2012 Honor Roll, said Karen Stoneman, Vice President of Human Resources, Sysmex America.

From Sysmex America, Inc. 17 Mar 2012

WASM, Philips partner to raise awareness of sleep disorders

Royal Philips Electronics will join with the World Association of Sleep Medicine (WASM) as an official sponsor of World Sleep Day 2012, held on Friday, March 16. This year's theme– 'Breathe Easily, Sleep Well' – centers on raising awareness of sleep disorders that affect a person's breathing, such as obstructive sleep apnea.

17 Mar 2012

Einstein members celebrate 2012 Match Day

Members of Albert Einstein College of Medicine of Yeshiva University's graduating class celebrated another strong year for residency placements in competitive specialties and prestigious programs at this year's Match Day. Representing the culmination of their medical school education, Match Day marked the transition of Einstein's class of 2012 into the post-graduate phase of their training - when they will practice medicine in a clinical setting under the supervision of fully licensed physicians.

17 Mar 2012

Repligen total revenue increases to $7,165,000 for quarter ended December 31, 2011

Repligen Corporation today reported financial results for the quarter and nine-month fiscal year ended December 31, 2011.

17 Mar 2012

Collaborative research discovers genetic marker that identifies pigs with reduced susceptibility to PRRS

A collaborative discovery involving Kansas State University researchers may improve animal health and save the U.S. pork industry millions of dollars each year.

16 Mar 2012

Novel sensor selectively screens single molecules passing through nanopores

A novel type of sensor, based on nanometer-scale pores in a semiconductor membrane, is a step closer to practical use in applications such as analyzing the protein contents of a single cell. Researchers pioneering single-molecule nanopore sensor technology at the Technische Universit-t M-nchen (TUM) have shown its potential through a succession of experiments over the past few years.

16 Mar 2012

Panel of 10 serum protein biomarkers could help in lung cancer diagnosis

A panel of serum biomarkers could help predict the level of lung cancer risk in high-risk patients, offering doctors an option before proceeding with a biopsy. Research presented in the April 2012 issue of the International Association for the Study of Lung Cancer's (IASLC) Journal of Thoracic Oncology shows that a panel of 10 serum protein biomarkers could help in the lung cancer diagnosis.

16 Mar 2012